Floatz logo

Eptacog Alfa

Hemophilia A, Hemophilia B

BayerPhase 2/3Dormant
B
61/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
46/ 100
Competitive Position
95/ 100

Competitive context

0 Active assets in the Hemophilia A, Hemophilia B cohort.

Asset / SponsorPhaseRating
Bay Factor Vii
Bayer
Phase 2/3B

Same molecule, other indications

Eptacog Alfa is also rated in:

hemophilia BDormant
A
Indicative ·
84 / 100
View asset →
hemophilia ADormant
A
Indicative ·
84 / 100
View asset →
inherited blood coagulation disorderDormant
A
Indicative ·
82 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →